The Cboe BZX Alternate has submitted a submitting with the U.S. Securities and Alternate Fee (SEC) searching for approval for a brand new exchange-traded fund (ETF) that may observe Injective’s native token (INJ).
The proposed product, named the Canary Staked INJ ETF, is sponsored by Canary Capital Group LLC, which initially launched the idea earlier this month.
The submitting marks a continued push towards increasing crypto ETF choices within the U.S. market, significantly past Bitcoin and Ethereum. The INJ-based fund would give traders direct publicity to the Injective ecosystem via a regulated funding automobile, ought to it obtain SEC approval.
On the identical day, Cboe BZX additionally filed a registration for the Invesco Galaxy Solana ETF, reinforcing the pattern of main asset managers pursuing spot ETFs for different Layer 1 blockchain tokens. Curiosity in a spot Solana ETF has grown steadily following comparable proposals from corporations like VanEck and 21Shares.
Each ETF proposals have been submitted utilizing the SEC’s commonplace two-step course of, which incorporates an preliminary 19b-4 submitting by the change adopted by a corresponding S-1 or belief registration by the sponsor. These filings are the formal starting of the regulatory evaluate cycle.
The simultaneous filings for each INJ and SOL ETFs mirror a broader shift within the crypto funding panorama, as asset managers race to carry new blockchain-native property into the normal monetary system via compliant, exchange-traded constructions.
Kosta has been working within the crypto trade for over 4 years. He strives to current totally different views on a given matter and enjoys the sector for its transparency and dynamism. In his work, he focuses on balanced protection of occasions and developments within the crypto house, offering info to his readers from a impartial perspective.
